Notice Type
Renewal of Provisional Consent to the Distribution of a New Medicine Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Indinavir sulphate 250 mg, 500 mg, equivalent to 200 mg, 400 mg indinavir Capsules, powder filled Merck & Co Inc., Elkton, Virginia, United States of America Crixivan Note: This consent is valid for 2 years from 26 September 1998. Dated this 17th day of July 1998. G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.
Publication Date
23 Jul 1998

Notice Number


Page Number